EUVIMEDEUVIMED entdecken
Crossref

Bombay and para-Bombay blood group phenotypes: Molecular basis, epidemiology, diagnosis, and transfusion management: An extended review

B.D.H. Al Khayali, Hind Mahmood Jumaah, Ali Muhsin Ali

Magna Scientia Advanced Research and Reviews · 31.03.2026 · 16 (2) · 042-049

DOI: 10.30574/msarr.2026.16.2.0032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magna Scientia Advanced Research and Reviews, online erschienen am 31.03.2026. Verfasst von B.D.H. Al Khayali und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bombay (Oh) and Para-Bombay are rare variants of the ABO blood group system that carry significant clinical importance. They are characterized by the absence or a marked reduction in the expression of the H antigen on red blood cells (RBCs). This deficiency leads to a failure in the synthesis of A and B antigens, predisposing patients—particularly those with the Bombay phenotype—to developing potent anti-H antibodies, which can cause severe hemolytic transfusion reactions.

Objective

The primary goal is to provide clinicians and laboratory specialists with a practical and comprehensive framework to prevent avoidable blood mismatch and improve clinical outcomes for patients suffering from H-deficient phenotypes.

Methods

This review summarizes the underlying biology behind FUT1/FUT2 deficiency and highlights its effects on population groups and founder effects. It integrates serological and molecular tools into a practical diagnostic workflow. Furthermore, it outlines management strategies for pre-surgery, obstetrics, and emergencies, and reviews emerging translational methods, such as the enzymatic removal of H from group O red blood cells.

Findings

The review emphasizes the critical nature of early engagement with rare donor networks. It identifies the biological mechanisms of H deficiency and provides a structured approach to managing the risks associated with these rare phenotypes, ensuring that high-potency antibodies do not lead to life-threatening transfusion complications.

Conclusion

Implementing a practical and comprehensive framework in laboratories is essential to prevent transfusion incompatibility. By utilizing advanced diagnostic tools and early coordination with donor networks, the safety and outcomes of patients with H antigen deficiency can be significantly enhanced.

Zitieren

APA

Khayali, B. A., Jumaah, H. M., & Ali, A. M. (2026). Bombay and para-Bombay blood group phenotypes: Molecular basis, epidemiology, diagnosis, and transfusion management: An extended review. Magna Scientia Advanced Research and Reviews, 16(2), 042-049. https://doi.org/10.30574/msarr.2026.16.2.0032

Vancouver

Khayali BA, Jumaah HM, Ali AM. Bombay and para-Bombay blood group phenotypes: Molecular basis, epidemiology, diagnosis, and transfusion management: An extended review. Magna Scientia Advanced Research and Reviews. 2026;16(2):042-049. doi:10.30574/msarr.2026.16.2.0032

BibTeX
@article{Khayali2026,
  author = {Khayali, B.D.H. Al and Jumaah, Hind Mahmood and Ali, Ali Muhsin},
  title = {Bombay and para-Bombay blood group phenotypes: Molecular basis, epidemiology, diagnosis, and transfusion management: An extended review},
  journal = {Magna Scientia Advanced Research and Reviews},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {042--049},
  doi = {10.30574/msarr.2026.16.2.0032}
}
Kostenlos starten →